The post HYPE Targets Break Above $36.64 Resistance After Solid Wave-2 Pullback appeared on BitcoinEthereumNews.com. Key Insights: HYPE shows strong recovery fromThe post HYPE Targets Break Above $36.64 Resistance After Solid Wave-2 Pullback appeared on BitcoinEthereumNews.com. Key Insights: HYPE shows strong recovery from

HYPE Targets Break Above $36.64 Resistance After Solid Wave-2 Pullback

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Key Insights:

  • HYPE shows strong recovery from $26 support zone, targeting $36.64 resistance breakout.
  • Hyperliquid generates $2M+ in fees with decentralized perpetual markets active even weekends.
  • 41.71 million HYPE tokens burned, reducing supply and boosting potential for price increase.
HYPE Targets Break Above $36.64 Resistance After Solid Wave-2 Pullback

HYPE, one of the cryptocurrencies gaining attention recently, is seeing progress in its price movement. The market has been making strong advances since January. The recent correction tested key support levels, giving rise to expectations of a potential breakout above critical resistance levels. If the price can break and sustain above this level, it could signal a larger upward trend for the asset.

Market Movement and Key Levels

HYPE’s price has shown consistent positive action after its wave-2 retracement. The market produced a clean 5-wave advance, followed by a clear 3-wave pullback. According to market analysis, this correction tested the typical support zone around $26 USD, which aligns with the 61.8% retracement. 

As the price holds above this support, it suggests that HYPE’s bullish structure remains intact. As long as the January 21 low of $20.50 holds, the bullish outlook will stay in place. Traders are closely monitoring whether the token will break above the $36.64 resistance level.

Hyperliquid Price Movement | Source: X

A break above this level would indicate that the market could be forming a more stable base for continued growth. If the price fails to break resistance, another test of the support zone near $26 is likely. The situation remains fluid, and traders should watch for any changes in the price action closely.

On-Chain Developments and Fee Burn

Meanwhile, Hyperliquid has been seeing consistent performance, generating over $2 million in fees within 24 hours. The platform’s innovative approach, such as keeping decentralized perpetual markets open even on weekends, is fueling its growth. 

“Based on Mike S “On-chain commodities perps, especially during times when traditional finance markets are closed, have become attractive to traders.”

Moreover, Hyperliquid has implemented its HIP-3 update, which allows builders to deploy perpetual markets with a 50% fee share. In total, 41.71 million in the tokens, worth over $1.3 billion, have been bought back and burned, helping reduce the circulating supply. As this burn continues, the supply reduction could add further upward momentum to the token’s price.

DISCLAIMER: The information on this website is provided as general market commentary and does not constitute investment advice. We encourage you to do your own research before investing.

Source: https://coincu.com/analysis/hype-targets-break-above-36-64-resistance-after-solid-wave-2-pullback/

Market Opportunity
Hyperliquid Logo
Hyperliquid Price(HYPE)
$30.75
$30.75$30.75
+2.91%
USD
Hyperliquid (HYPE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09